Azenta, Inc. AZTA revenue by segment, product and geography
In its fiscal year ending 2025-09-30, Azenta, Inc. reported revenue across 3 business segments; the largest, Multiomics, was $269M, 45.3% of the filed sum (+5.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Multiomics$269M45.3%+5.8% yoy
- Core Products$198M33.3%+0.6% yoy
- Sample Repository Solutions$127M21.4%+3.7% yoy
Members sum to the consolidated $594M for this period.
- Service$421M70.8%+5.2% yoy
- Product$173M29.2%-0.3% yoy
Members sum to the consolidated $594M for this period.
- United States$365M61.5%0.0% yoy
- Europe$107M18.1%+12.8% yoy
- China$58.3M9.8%+0.2% yoy
- United Kingdom$35.4M6.0%+30.1% yoy
- Asia Pacific$23.3M3.9%+9.2% yoy
- Other$4.43M0.7%-31.5% yoy
Members sum to the consolidated $594M for this period.
- Sample Management Solutions$81.1Mshare n/a+1.6% yoy
- Multiomics$63.7Mshare n/a+0.3% yoy
- Core Products$44.3Mshare n/a-7.5% yoy
- Sample Repository Solutions$36.8Mshare n/a+15.2% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.